These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 8081765
21. Epitope mapping of the indirect T cell response to allogeneic class I MHC: sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production. Lovegrove E, Pettigrew GJ, Bolton EM, Bradley JA. J Immunol; 2001 Oct 15; 167(8):4338-44. PubMed ID: 11591757 [Abstract] [Full Text] [Related]
22. Heart allograft survival in rats following immunization with soluble peptide MHC class I donor antigens: evidence for the role of indirect recognition in rejection. Terness P, Dufter C, Post S, Thies J, Otto G, Koru T, Opelz G. Transpl Int; 1994 Oct 15; 7 Suppl 1():S584-5. PubMed ID: 11271314 [Abstract] [Full Text] [Related]
23. Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. Womer KL, Stone JR, Murphy B, Chandraker A, Sayegh MH. J Am Soc Nephrol; 2001 Nov 15; 12(11):2500-2506. PubMed ID: 11675428 [Abstract] [Full Text] [Related]
25. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection. Wood KJ, Hopley A, Dallman MJ, Morris PJ. Transplantation; 1988 Apr 15; 45(4):759-67. PubMed ID: 3282359 [Abstract] [Full Text] [Related]
26. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Garrovillo M, Ali A, Oluwole SF. Transplantation; 1999 Dec 27; 68(12):1827-34. PubMed ID: 10628758 [Abstract] [Full Text] [Related]
27. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. Fangmann J, Dalchau R, Fabre JW. Transplant Proc; 1993 Feb 27; 25(1 Pt 1):183-4. PubMed ID: 8438266 [No Abstract] [Full Text] [Related]
28. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Transplantation; 1993 Aug 27; 56(2):461-5. PubMed ID: 7689263 [Abstract] [Full Text] [Related]
29. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Vella JP, Magee C, Vos L, Womer K, Rennke H, Carpenter CB, Hancock W, Sayegh MH. Transplantation; 1999 Jun 27; 67(12):1523-32. PubMed ID: 10401758 [Abstract] [Full Text] [Related]
30. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model. Koch M, Broecker V, Heratizadeh A, Doege C, Strehlau J, Mengel M, Nashan B. Transpl Immunol; 2008 Jul 27; 19(3-4):187-91. PubMed ID: 18595711 [Abstract] [Full Text] [Related]
31. Role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in natural killer cell-mediated bone marrow allograft rejection in rats. Engh E, Benestad HB, Strøm-Gundersen I, Vaage JT, Bell EB, Rolstad B. Transplantation; 1998 Feb 15; 65(3):319-24. PubMed ID: 9484746 [Abstract] [Full Text] [Related]
32. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination. Wray DW, Baldwin WM, Sanfilippo F. Transplantation; 1993 May 15; 55(5):1132-8. PubMed ID: 8497894 [Abstract] [Full Text] [Related]
33. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts. Pettigrew GJ, Lovegrove E, Bradley JA, Maclean J, Bolton EM. J Immunol; 1998 Aug 01; 161(3):1292-8. PubMed ID: 9686590 [Abstract] [Full Text] [Related]
34. Prolongation of small bowel allograft survival with a sequential therapy consisting of a synthetic MHC class II peptide and temporarily low-dose cyclosporine A. Otto C, Gasser M, Waaga-Gasser AM, Rohde AC, Lenhard M, Jost S, Gassel HJ, Ulrichs K, Timmermann W. Hum Immunol; 2002 Oct 01; 63(10):880-7. PubMed ID: 12368040 [Abstract] [Full Text] [Related]
35. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity. Yamamoto S, Ito T, Nakata S, Nozaki S, Uchikoshi F, Shirakura R, Kamiike W, Miyata M, Matsuda H. Transplantation; 1994 Apr 27; 57(8):1217-22. PubMed ID: 7909966 [Abstract] [Full Text] [Related]
36. Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation. Tu Y, Arima T, Flye MW. Transplantation; 1997 Jan 27; 63(2):177-81. PubMed ID: 9020314 [Abstract] [Full Text] [Related]
37. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Transplantation; 1994 Feb 27; 57(4):572-6. PubMed ID: 8116044 [Abstract] [Full Text] [Related]
38. Modulation of the immune response with major histocompatability class II peptides via the indirect pathway of allorecognition after kidney and small bowel transplantation. Gasser M, Lenhard SM, Otto C, Kist-van Holthe JE, Navarro E, Timmermann W, Ulrichs K, Thiede A, Waaga AM. Transplant Proc; 2002 Sep 27; 34(6):2244-5. PubMed ID: 12270384 [No Abstract] [Full Text] [Related]
39. Role of indirect allorecognition in experimental late acute rejection. Vella JP, Vos L, Carpenter CB, Sayegh MH. Transplantation; 1997 Dec 27; 64(12):1823-8. PubMed ID: 9422426 [Abstract] [Full Text] [Related]